Replicable expression vector for bacterial expression of a mammalian polypeptide
Abstract
Refractile particles containing a heterologous polypeptide as an insoluble aggregate are recovered from bacterial periplasm. The process involves culturing bacterial cells so as to express nucleic acid encoding phage lysozyme and nucleic acid encoding the heterologous polypeptide under separate promoters, disrupting the cells mechanically to release the phage lysozyme so as to release refractile particles from the bacterial cellular matrix, and recovering the released refractile particles from the periplasm. Chloroform is not used in any step and the recovery step minimizes co-recovery of cellular debris with the released refractile particles.
Claims
exact text as granted — not AI-modified1. A replicable bacterial expression vector comprising a first nucleic acid encoding a mammalian polypeptide comprising a signal sequence for secretion into the periplasm, under control of a first inducible promoter, and a second nucleic acid encoding a phage lysozyme, in the absence of a signal sequence, under control of a second tightly-controlled inducible promoter, wherein said first and second promoters are different which can independently regulate the expression of said mammalian polypeptide and said phage lysozyme.
2. The replicable bacterial expression vector of claim 1 wherein the mammalian polypeptide is a human polypeptide.
3. The replicable bacterial expression vector of claim 2 wherein the human polypeptide is an insulin-like growth factor (IGF), DNAse, or vascular endothelial growth factor (VEGF).
4. The replicable bacterial expression vector of claim 3 wherein the human polypeptide is IGF-I.
5. The replicable bacterial expression vector of claim 4 wherein said first inducible promoter is an alkaline phosphatase promoter.
6. The replicable bacterial expression vector of claim 5 wherein said second tightly-controlled inducible promoter is an arabinose promoter.
7. The replicable bacterial expression vector of claim 6 wherein the the human polypeptide comprises a lamB signal sequence.
8. A bacterial host cell transformed with a replicable bacterial expression vector according to any one of claims 1 to 7 .
9. The bacterial host cell of claim 8 which is a Gram-negative cell.
10. The bacterial host cell of claim 9 which is an E. coli cell.
11. The bacterial host cell of claim 10 comprising a mammalian polypeptide encoded by said bacterial expression vector accumulated in the periplasm thereof.Join the waitlist — get patent alerts
Track US8183029B2 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.